According to the new market research report "Metagenomic Sequencing Market by
Product & Services (Reagent, Consumables, Instrument), Workflow (Sample
Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome),
Application (Drug Discovery, Diagnostic) - Global Forecast to 2027", published
by MarketsandMarkets™, the global market is expected to reach USD 4.3 billion by 2027 from USD 1.9 billion in 2022, at a CAGR of 18.4% during
the forecast period.
Browse in-depth TOC on "Metagenomic
Sequencing Market"
211 – Tables
41 – Figures
247 – Pages
The Growth in the metagenomic sequencing market is
mainly driven by continuous technological innovations in NGS platforms,
increasing initiatives and funding from government & private bodies for
large-scale sequencing projects, declining costs of genome sequencing, and the
significant applications of metagenomics in various fields.
The drug discovery segment accounted for the largest
share of the metagenomic sequencing in 2021.
Based on applications, the metagenomic sequencing
market is segmented into drug discovery, clinical diagnostics, soil microbiome
applications, industrial applications, ecological & environmental
applications, veterinary applications, and other applications. The drug
discovery segment accounted for the largest share of the market in 2021. The
large share of this segment can be attributed to the increasing research
activities for novel drug discovery and growing collaborations between market
players, academic institutions, and pharmaceutical companies for drug
development.
The reagents & consumables segment accounted for
the largest share of the metagenomic sequencing in 2021.
Based on products & services, the metagenomic sequencing market is segmented into reagents & consumables, instruments, services, and analysis & data interpretation solutions. The reagents & consumables segment accounted for the largest share of the market in 2021. Factors such as the development and commercialization of high-quality reagents and kits and the continuous requirement of sequencing reagents by end users are expected to drive the growth of this segment in the market.
The Asia
Pacific region is the fastest-growing region of the
metagenomic sequencing in 2021.
The market in the Asia Pacific is
expected to register the highest growth rate during the forecast period,
primarily due to the increasing financial support from public as well as
private agencies, the increasing number of NGS-based research projects,
increasing awareness about precision medicine, and the rising prevalence of
chronic diseases.
Some of the leading players operating in the
metagenomic sequencing market are Illumina, Inc. (US), Thermo Fisher Scientific
(US), QIAGEN N.V. (Netherlands),
PerkinElmer, Inc. (US), and Oxford Nanopore Technologies Plc. (UK).
Browse Related Reports:
Genomics Market by
Product & Service (System & Software, Consumables, Services),
Technology (Sequencing, PCR), Application (Drug Discovery & Development,
Diagnostic, Agriculture), End User (Hospital & Clinics, Research Centers) –
Global Forecast to 2025
Contact:
Sanjay S
Team Lead
Phone : +1-888-600-6441
Email : sanjay.sutar@marketsandmarkets.com